Horizon BioAdvance is a clinical research site located in Lafayette, Indiana, United States 47905.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
Horizon BioAdvance has participated in 3 clinical trials.
Therapeutic areas: Solid Tumors, Non Small Cell Lung Carcinoma, Waldenstrom's Macroglobulinemia.
Sponsors: Endocyte, Idera Pharmaceuticals, Inc., pharmaand GmbH.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Horizon BioAdvance has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Horizon BioAdvance has 3 clinical trials on record. Their work covers Solid Tumors, Non Small Cell Lung Carcinoma, Waldenstrom's Macroglobulinemia.
Horizon BioAdvance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.